期刊文献+

基因工程菌SIPI-A0707代谢产物表柔红霉素的分离纯化工艺研究 被引量:1

Study on the separation and purification of 4'-epi-daunorubicin produced by gene engineering strain SIPI-A0707
下载PDF
导出
摘要 目的建立天蓝淡红链霉菌基因工程菌(SIPI-A0707)发酵液中表柔红霉素的分离纯化工艺。方法调节发酵液pH值为5,用甲醇抽提表柔红霉素;先采用大孔弱酸性阳离子交换树脂D152,吸附流速为2mL/min,0.05mol/L HCl-50%丙酮解吸;然后采用氯仿-水萃取体系,萃取pH为6.5,反萃取使用pH为1.5的蒸馏水,最后采用大孔吸附树脂Microsphere-1;吸附pH为7,吸附流速3mL/min,50%甲醇解吸分步收集,浓缩冻干。结果表柔红霉素HPLC纯度达到98.1%,总收率为40%以上。结论此工艺在生产上可行性较高,适合工业大量制备。 Objective To establish a separation and purification process of 4'-epi-daunorubicin from fermentation broth of gene engineering strain Streptomyces coeruleorubidus (SIPI-A0707). Methods Adjusted the pH value of fermentation broth to 5 and extracted 4'-epi-daunorubicin with methanol. Firstly macroporous weak acid cation exchange resin D152 was used and the adsorption flow rate was 2mL/min, 0.05mol/L HC1-50% acetone was used as desorption agent. Then chloroform-water extraction system was studied which showed the optimized extraction pH value was 6.5 and distilled water with pH 1.5 was used as reextraction agent. Finally macroporous resin Microsphere-1 was used and the adsorption pH value was 7, the adsorption flow rate was 3mL/min, 50% methanol was used as desorption agent and fractions were collected, decompressed and freeze-dried. Results The HPLC purity of 4'-epi-daunorubicin was over 98.1%, total yield was over 40%. Conclusion The extraction process of 4'-epi- daunorubicin is easy to scale-up for industrial preparation.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2011年第11期839-843,共5页 Chinese Journal of Antibiotics
基金 国家"重大新药创制"科技重大专项资助项(No.2009ZX09301-007)
关键词 表柔红霉素 基因工程菌株 分离纯化 4'-epi-daunorubicin Gene engineering strain Separation and purification
  • 相关文献

参考文献7

二级参考文献25

  • 1周惠燕,章辉,李士敏.竹叶化学成分研究Ⅰ[J].中国中药杂志,2005,30(24):1933-1934. 被引量:47
  • 2孙长花,张素华,张凌云.竹叶黄酮的生理活性与应用研究[J].四川食品与发酵,2006,42(1):13-16. 被引量:23
  • 3陈复生,左锦静,姚永志.大孔树脂吸附和分离陈皮中黄酮类化合物的研究[J].食品科技,2006,31(7):121-124. 被引量:10
  • 4徐国良,肖兵华,邹胡斌,陈奇.大孔吸附树脂分离肿节风中总黄酮的研究[J].中草药,2006,37(7):1014-1017. 被引量:22
  • 5van tier Rijst M, Scheeren JW, de Vos D. Process tbr preparing epirubicin or acid addition salts thereof daunorubicin: US, 5874550[ P]. 1999-02-23.
  • 6Otten SL,Gallo MA,Madduri K,et al. Cloning and characterization of the Streptomyces peucetius dnmZUV genes encoding three enzymes required for biosynthesis of the daunorubicin precursor thymidine diphospho-L-daunosamine[J]. J Bacteriol,1997 ,179 (13) :4 446 -4 450.
  • 7Hutchinson CR, Colombo AL. Genetic engineering of doxorubicin production in Streptomyces peucetius : a review [ J ]. J Ind Microbiol Biotechnol, 1999,23 ( 1 ) :647 - 652.
  • 8Madduri K, Kennedy J, Rivola G,et al. Production of the antitu- mor drug epirubicin ( 4'-epidoxorubicin ) and its precursor by a genetically engineered strain of Streptomyces peucetius [ J ]. Nat Biotechnol, 1998,16( 1 ) :69 - 74.
  • 9Lomovskaya N, Otten SL,Doi-Katayama Y ,et al. Doxorubicin overproduction in Streptomyces peucetius : cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P450 hydroxylase gene[ J ]. J Bacteriol, 1999,181 ( 1 ) : 305 -318.
  • 10Kim W, Lee D, Hong SS ,et al. Rational biosynthetic engineering for optimization of geldanamycin analogues[ J]. ChemBioChem, 2009,10(7) :1 243 -1 251.

共引文献25

同被引文献15

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部